Patent application number | Description | Published |
20100063137 | Cytotoxin Compound And Method of Isolation - The present invention concerns compounds derived from tunicates of the species | 03-11-2010 |
20110189221 | NOVEL ANTIVIRAL COMPOUNDS FROM MARINE EXTRACTS - The subject invention pertains to novel biologically active extracts from marine algae and to biologically active fractions and components of these extracts. These extracts have been shown to possess antiviral properties. Pharmaceutical compositions comprising these extracts, or comprising biologically active fractions or components of these extracts, could be used in the treatment of viral diseases including influenza. | 08-04-2011 |
20130184353 | MATERIALS AND METHODS FOR REDUCTION OF PROTEIN TAU AND TREATMENT OF NEURODEGENERATIVE DISEASES - The subject invention provides a myricanol compound that is in predominant form of (+)-αR,11S-myricanol as compared to (−)-αS,11R-myricanol. In one embodiment, the (+)-αR,11S-myricanol is isolated from | 07-18-2013 |
20140194495 | CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION - The present invention concerns groups of compounds derived from tunicates of the | 07-10-2014 |
20140274883 | NOVEL ANTIVIRAL COMPOUNDS FROM MARINE EXTRACTS - The subject invention pertains to novel biologically active extracts from marine algae and to biologically active fractions and components of these extracts. These extracts have been shown to possess antiviral properties. Pharmaceutical compositions comprising these extracts, or comprising biologically active fractions or components of these extracts, could be used in the treatment of viral diseases including influenza. | 09-18-2014 |
20150051294 | Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases - The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau. | 02-19-2015 |
20150072029 | MATERIALS AND METHODS FOR REDUCTION OF PROTEIN TAU AND TREATMENT OF NEURODEGENERATIVE DISEASES - The subject invention provides a myricanol compound that is in predominant form of (+)-αR,11S-myricanol as compared to (−)-αS,11R-myricanol. In one embodiment, the (+)-αR,11S-myricanol is isolated from | 03-12-2015 |
20160030388 | DITERPENOID MEMBRANOLIDE COMPOUNDS HAVING ANTI-LEISHMANIA ACTIVITY AND USES THEREOF - In a screening program, the Antarctic sponge | 02-04-2016 |